Mitotan
Mitotan
- CAS:
- 53-19-0
- MF:
- C14H10Cl4
- MW:
- 320.04
Suppliers by country/region
Company Type
Properties
- Melting point:
- 77-78 °C(lit.)
- Boiling point:
- 405.59°C (rough estimate)
- Density
- 1.3118 (rough estimate)
- refractive index
- 1.6000 (estimate)
- storage temp.
- Inert atmosphere,Room Temperature
- solubility
- DMSO: soluble20mg/mL, clear
- form
- powder
- color
- white to beige
- Water Solubility
- <0.1 g/100 mL at 24 ºC
- Merck
- 13,6237 / 13,6237
- BRN
- 2056007
- InChI
- InChI=1S/C14H10Cl4/c15-10-7-5-9(6-8-10)13(14(17)18)11-3-1-2-4-12(11)16/h1-8,13-14H
- InChIKey
- JWBOIMRXGHLCPP-UHFFFAOYSA-N
- SMILES
- C1(Cl)=CC=CC=C1C(C1=CC=C(Cl)C=C1)C(Cl)Cl
Safety Information
- Symbol(GHS)
GHS08
- Signal word
- Warning
- Hazard statements
- H351
- Precautionary statements
- P280
- Hazard Codes
- Xn
- Risk Statements
- 40
- Safety Statements
- 36/37
- RIDADR
- 3249
- WGK Germany
- 3
- RTECS
- KH7880000
- HazardClass
- 6.1(b)
- PackingGroup
- III
- HS Code
- 2903990002
Use
Mitotane is an inhibitor of steroidogenesis that suppresses the growth of adrenocortical cells. It blocks the expression of several genes that encode proteins involved in steroidogenesis and disrupts mitochondrial respiratory chain activity in human adrenocortical cells. Mitotane has anti-neoplastic actions, alone or in combination with other compounds, and suppresses cortisol synthesis, although it also has significant toxicity in the gastrointestinal tract and nervous system. It is effective against adrenocortical carcinoma and Cushing’s Syndrome in clinical trials.
2 India supplier list of "Mitotan"
- Product Name:2,4′-DDD
- Products Intro:Brand:sigma aldrich | Product Number:35485 | Purity:PESTANAL?,analyticalstandard
- Company Type: Trader
- Country/Region: INDIA
- Product Name:Mitotan
- Company Type: Reagent
- Country/Region: INDIA
- Product Name:Mitotane(1445007)
- Products Intro:Brand:pharmaffiliates | Product Number:PAUSP1445007
- Company Type: Trader
- Country/Region: INDIA